Nurse Practitioner · Montvale, NJ
NPI
1841897824
Since 2020
Specialty
Nurse Practitioner
Code 163WX0200X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
225 Summit Ave
Montvale, NJ, 07645
Phone (201) 775-7513
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
322 services
Medicare patients, 2024
177
Average age 75
Drug cost, 2024
$3.4M
455 prescriptions
Company payments, 2025
$470
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer Abillar-Wright was code 99215 (office e&m - established), 170 times for 113 patients. In total Jennifer Abillar-Wright billed 322 services in 7 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 170 | 113 | $105.81 | $18K |
| 99214 Office E&M - Established | Office | 87 | 65 | $64.36 | $5,599 |
| 38222 Other Organ Systems | Office | 29 | 29 | $54.54 | $1,582 |
By year: 2022 $15K for 178 services; 2023 $9,767 for 112 services; 2024 $27K for 322 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer Abillar-Wright prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 98 prescriptions and refills. In total Jennifer Abillar-Wright wrote 455 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 98 | 98 | 15 | $1.6M |
| Hydroxyurea Generic | 65 | 139 | 20 | $2,919 |
| Allopurinol Generic | 50 | 115 | 17 | $581 |
| Sprycel Dasatinib | 23 | 23 | Under 11 | $234K |
| Acyclovir Generic | 22 | 28 | Under 11 | $264 |
| Prednisone Generic | 21 | 21 | Under 11 | $92.55 |
| Scemblix Asciminib Hydrochloride | 21 | 21 | Under 11 | $454K |
| Tasigna Nilotinib Hcl | 19 | 19 | Under 11 | $250K |
| Vonjo Pacritinib Citrate | 18 | 18 | Under 11 | $466K |
| Xarelto Rivaroxaban | 11 | 15 | Under 11 | $7,923 |
Brand drugs: 213 claims; generic drugs: 242 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer Abillar-Wright $470 ($470 in general payments such as food, travel and fees) from 4 companies. The largest payer was GlaxoSmithKline, LLC. with $156.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.